GlassScriptPhysician profile
Erin Deal
NPI 1851986277
$1,152.38
in general payments reported to CMS, 2019-2025
22 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $213 · 2024: $636 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.01 | 2023-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.28 | 2023-2025 | Jardiance |
| Amgen INC. | $94.59 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $72.28 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $71.25 | 2023-2025 | Tagrisso, Brilinta |
| Surmodics, INC. | $68.20 | 2024-2025 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Sanofi-Aventis U.S. LLC | $52.12 | 2023-2024 | |
| Pfizer INC. | $40.27 | 2024 | |
| Glaxosmithkline, LLC. | $35.38 | 2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $31.15 | 2023 | Verquvo, Keytruda |
| Ethicon US, LLC | $22.58 | 2024 | Surgicel Nu-Knit, Dermabond Prineo, Vistaseal |
| Baxter Healthcare | $21.70 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $21.00 | 2025 | Ozempic |
| Alnylam Pharmaceuticals INC. | $19.67 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $18.79 | 2025 | Camzyos |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $18.46 | 2025 | Tyvaso |
| Solventum Corporation | $17.49 | 2024 | Prevena, V.A.C.Instill, 3m Cavilon |
| Siemens Medical Solutions USA, INC. | $17.21 | 2024 | Cios Spin |
| Electromed, INC. | $15.59 | 2023 | Smartvest |
| Ultragenyx Pharmaceutical INC. | $15.55 | 2024 | Dojolvi |
| Inspire Medical Systems, INC. | $15.51 | 2024 | Inspire |
| Philips North America LLC | $14.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Deal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.